191 related articles for article (PubMed ID: 12796380)
1. Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma.
Zhang ZW; Newcomb P; Hollowood A; Feakins R; Moorghen M; Storey A; Farthing MJ; Alderson D; Holly J
Clin Cancer Res; 2003 Jun; 9(6):2151-6. PubMed ID: 12796380
[TBL] [Abstract][Full Text] [Related]
2. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
[TBL] [Abstract][Full Text] [Related]
3. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
Lai KC; Chen WC; Tsai FJ; Li SY; Jeng LB
Hepatogastroenterology; 2005; 52(63):944-8. PubMed ID: 15966238
[TBL] [Abstract][Full Text] [Related]
4. The p53 codon 72 polymorphism and lung cancer risk.
Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
[TBL] [Abstract][Full Text] [Related]
5. TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.
Kim JG; Sohn SK; Chae YS; Song HS; Kwon KY; Do YR; Kim MK; Lee KH; Hyun MS; Lee WS; Sohn CH; Jung JS; Kim GC; Chung HY; Yu W
Cancer Chemother Pharmacol; 2009 Jul; 64(2):355-60. PubMed ID: 19052714
[TBL] [Abstract][Full Text] [Related]
6. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.
Wang YC; Chen CY; Chen SK; Chang YY; Lin P
Clin Cancer Res; 1999 Jan; 5(1):129-34. PubMed ID: 9918210
[TBL] [Abstract][Full Text] [Related]
7. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
Hu Y; McDermott MP; Ahrendt SA
Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
[TBL] [Abstract][Full Text] [Related]
8. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y
Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804
[TBL] [Abstract][Full Text] [Related]
9. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer.
Granja F; Morari J; Morari EC; Correa LA; Assumpção LV; Ward LS
Cancer Lett; 2004 Jul; 210(2):151-7. PubMed ID: 15183530
[TBL] [Abstract][Full Text] [Related]
10. Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan.
Wu MT; Chen MC; Wu DC
Cancer Lett; 2004 Mar; 205(1):61-8. PubMed ID: 15036662
[TBL] [Abstract][Full Text] [Related]
11. Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma.
Boltze C; Roessner A; Landt O; Szibor R; Peters B; Schneider-Stock R
Int J Oncol; 2002 Nov; 21(5):1151-4. PubMed ID: 12370767
[TBL] [Abstract][Full Text] [Related]
12. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
Bhattacharya P; Sengupta S
Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
[TBL] [Abstract][Full Text] [Related]
13. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
Jiang P; Liu J; Zeng X; Li W; Tang J
Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
[TBL] [Abstract][Full Text] [Related]
14. Determination of p53 genotypes in oral cancer patients from India.
Tandle AT; Sanghvi V; Saranath D
Br J Cancer; 2001 Mar; 84(6):739-42. PubMed ID: 11259085
[TBL] [Abstract][Full Text] [Related]
15. The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer.
Lee JM; Shun CT; Wu MT; Chen YY; Yang SY; Hung HI; Chen JS; Hsu HH; Huang PM; Kuo SW; Lee YC
Mutat Res; 2006 Feb; 594(1-2):181-8. PubMed ID: 16318864
[TBL] [Abstract][Full Text] [Related]
16. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
[TBL] [Abstract][Full Text] [Related]
17. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
[TBL] [Abstract][Full Text] [Related]
18. p 53 codon 72 polymorphism in stomach and colorectal adenocarcinomas in Iranian patients.
Mojtahedi Z; Haghshenas MR; Hosseini SV; Fattahi MJ; Ghaderi A
Indian J Cancer; 2010; 47(1):31-4. PubMed ID: 20071787
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the frequency of TP53 gene codon 72 polymorphisms in Iranian patients with endometrial cancer.
Ghasemi N; Karimi-Zarchi M; Mortazavi-Zadeh MR; Atash-Afza A
Cancer Genet Cytogenet; 2010 Jan; 196(2):167-70. PubMed ID: 20082853
[TBL] [Abstract][Full Text] [Related]
20. Germline polymorphism of p53 codon 72 in gynecological cancer.
Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Yamaguchi H; Nishiyama K; Yasuda M; Ueki M
Gynecol Oncol; 2006 Jan; 100(1):173-8. PubMed ID: 16168468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
